Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Warts 1Uterine Cervical Neoplasms 1Urinary Tract Infections 1Staphylococcal Infections 1Squamous Intraepithelial Lesions 1Spasm 1Sleep Initiation and Maintenance Disorders 1Sepsis 1Seizures 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Pneumonia 1Pain 1Neutropenia 1Migraine Disorders 1Menorrhagia 1Meningitis, Bacterial 1Meningitis 1Intraabdominal Infections 1Influenza, Human 1Inflammation 1Infections 1Hypokalemia 1Hypertension 1Hyperaldosteronism 1High-grade Anal Intraepithelial Neoplasia 1Herpes Simplex 1

Interventions

Cryotherapy 11Salicylic Acid 3PRA1 protein, Candida albicans 3Cholecalciferol 3Cantharidin 3Tuberculin 2Solutions 2Sodium Chloride 2Saline Solution 2Percutaneous Collagen Induction 2Measles-Mumps-Rubella Vaccine 2Lasers 2Hydrogen Peroxide 2Human Papillomavirus Recombinant Vaccine nonavalent 2leupin 1lactic acid, salicylic acid drug combination 1green tea extract polyphenone E 1Zinc Sulfate 1Zinc 1Vitamin D 1Vaccination 1Trichloroacetic Acid 1Pyruvic Acid 1Photochemotherapy 1Methylene Blue 1Mass Screening 1Lasers, Solid-State 1Lasers, Gas 1Laser Therapy 1Ivermectin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Warts × Cidofovir × Clear all
NCT02567149 2017-07-02

Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population.

University of Minnesota

Phase 2 Withdrawn

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡